Record 38,902 new COVID-19 cases in last 24 hours take India's tally to 10.77 lakh, death toll at 26,816 | Check state-wise list here
New Delhi | Jagran News Desk: With 38,902 new coronavirus cases in last 24 hours, biggest single-day spike ever, India's COVID-19 tally on Sunday reached 10,77,618, said the Ministry of Health and Family Welfare. According to the Union Health Ministry, 543 fatalities were reported during the same period, taking India's death toll to 26,816.
As per the data available at the Health Ministry website, there are 3,73,379 active coronavirus cases in India while the recovery rate stands at 62.86. 6,77,423 people have been cured from coronavirus and discharged from hospitals, the Health Ministry noted.
Maharashtra, which is the worst affected state in India, on Sunday also crossed the grim mark of 3 lakh coronavirus cases while death toll has increased to 11,596. Tamil Nadu and Delhi have reported 1.65 lakh and 1.25 lakh coronavirus cases respectively while Karnataka has reported nearly 60,000 COVID-19 cases.
The cases of the highly contagious coronavirus in India have been growing at an alarming rate. Looking at the surge, Prime Minister Narendra Modi in his last address to the nation had appealed people to practice social distancing and follow the guidelines issued by the government. The Prime Minister has also said that the India's grass-root system has helped the country ensure one of the best recovery rate in the world.
Here's the state-wise report on coronavirus pandemic in India:
|Name of State/UT||Active Cases||Cured/Discharged/Migrated||Deaths||Total Confirmed cases|
|Andaman and Nicobar Islands||53||145||0||198|
|Dadra and Nagar Haveli and Daman and Diu||186||414||2||602|
|Jammu and Kashmir||5797||7165||236||13198|
AIIMS panel nod to human clinical trial of Covaxin
Meanwhile, the AIIMS on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin. In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
"The AIIMS Ethics Committee gave its approval for starting the human clinical trial of the indigenously developed Covaxin today. Healthy volunteers having no comorbid conditions and without a history of COVID-19, aged more than 18 years and less than 55 years, would be eligible to participate in the randomised, double-blind, placebo-controlled clinical trial," Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS said.
"Few volunteers have already registered for the trial. We would start the screening of the individuals and evaluate their health condition from Monday onwards before vaccinating them," Rai, who is also the principal investigator of the study, said.
(With PTI inputs)
Posted By: Aalok Sensharma